Cargando…

The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons

BACKGROUND: Altered Na(+ )channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun-Gang, Strong, Judith A, Xie, Wenrui, Yang, Rui-Hua, Coyle, Dennis E, Wick, Dayna M, Dorsey, Ericka D, Zhang, Jun-Ming
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562993/
https://www.ncbi.nlm.nih.gov/pubmed/18816377
http://dx.doi.org/10.1186/1744-8069-4-38
_version_ 1782159780028088320
author Wang, Jun-Gang
Strong, Judith A
Xie, Wenrui
Yang, Rui-Hua
Coyle, Dennis E
Wick, Dayna M
Dorsey, Ericka D
Zhang, Jun-Ming
author_facet Wang, Jun-Gang
Strong, Judith A
Xie, Wenrui
Yang, Rui-Hua
Coyle, Dennis E
Wick, Dayna M
Dorsey, Ericka D
Zhang, Jun-Ming
author_sort Wang, Jun-Gang
collection PubMed
description BACKGROUND: Altered Na(+ )channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is known about its direct effects on neurons. RESULTS: We report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of Na(+ )currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2- to 4 fold, without altered voltage dependence or kinetic changes. These effects required long exposures, and were completely blocked by co-incubation with protein synthesis inhibitor cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel isoforms were predominant both before and after GRO/KC treatment (Na(v )1.1, 1.7, and 1.8). TTX-sensitive isoforms 1.1 and 1.7 significantly increased 2 – 3 fold after GRO/KC incubation, while 1.8 showed a trend towards increased expression. Current clamp experiments showed that GRO/KC caused a marked increase in excitability, including resting potential depolarization, decreased rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire repetitively; IB4-positive cells also showed marked broadening of action potentials. Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS. CONCLUSION: Many studies on the role of chemokines in pain conditions have focused on their rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis.
format Text
id pubmed-2562993
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25629932008-10-08 The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons Wang, Jun-Gang Strong, Judith A Xie, Wenrui Yang, Rui-Hua Coyle, Dennis E Wick, Dayna M Dorsey, Ericka D Zhang, Jun-Ming Mol Pain Research BACKGROUND: Altered Na(+ )channel expression, enhanced excitability, and spontaneous activity occur in nerve-injury and inflammatory models of pathological pain, through poorly understood mechanisms. The cytokine GRO/KC (growth related oncogene; CXCL1) shows strong, rapid upregulation in dorsal root ganglion in both nerve injury and inflammatory models. Neurons and glia express its receptor (CXCR2). CXCL1 has well-known effects on immune cells, but little is known about its direct effects on neurons. RESULTS: We report that GRO/KC incubation (1.5 nM, overnight) caused marked upregulation of Na(+ )currents in acutely isolated small diameter rat (adult) sensory neurons in vitro. In both IB4-positive and IB4-negative sensory neurons, TTX-resistant and TTX-sensitive currents increased 2- to 4 fold, without altered voltage dependence or kinetic changes. These effects required long exposures, and were completely blocked by co-incubation with protein synthesis inhibitor cycloheximide. Amplification of cDNA from the neuronal cultures showed that 3 Na channel isoforms were predominant both before and after GRO/KC treatment (Na(v )1.1, 1.7, and 1.8). TTX-sensitive isoforms 1.1 and 1.7 significantly increased 2 – 3 fold after GRO/KC incubation, while 1.8 showed a trend towards increased expression. Current clamp experiments showed that GRO/KC caused a marked increase in excitability, including resting potential depolarization, decreased rheobase, and lower action potential threshold. Neurons acquired a striking ability to fire repetitively; IB4-positive cells also showed marked broadening of action potentials. Immunohistochemical labelling confirmed that the CXCR2 receptor was present in most neurons both in dissociated cells and in DRG sections, as previously shown for neurons in the CNS. CONCLUSION: Many studies on the role of chemokines in pain conditions have focused on their rapid and indirect effects on neurons, via release of inflammatory mediators from immune and glial cells. Our study suggests that GRO/KC may also have important pro-nociceptive effects via its direct actions on sensory neurons, and may induce long-term changes that involve protein synthesis. BioMed Central 2008-09-24 /pmc/articles/PMC2562993/ /pubmed/18816377 http://dx.doi.org/10.1186/1744-8069-4-38 Text en Copyright © 2008 Wang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wang, Jun-Gang
Strong, Judith A
Xie, Wenrui
Yang, Rui-Hua
Coyle, Dennis E
Wick, Dayna M
Dorsey, Ericka D
Zhang, Jun-Ming
The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons
title The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons
title_full The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons
title_fullStr The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons
title_full_unstemmed The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons
title_short The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons
title_sort chemokine cxcl1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562993/
https://www.ncbi.nlm.nih.gov/pubmed/18816377
http://dx.doi.org/10.1186/1744-8069-4-38
work_keys_str_mv AT wangjungang thechemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT strongjuditha thechemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT xiewenrui thechemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT yangruihua thechemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT coyledennise thechemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT wickdaynam thechemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT dorseyerickad thechemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT zhangjunming thechemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT wangjungang chemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT strongjuditha chemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT xiewenrui chemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT yangruihua chemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT coyledennise chemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT wickdaynam chemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT dorseyerickad chemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons
AT zhangjunming chemokinecxcl1growthrelatedoncogeneincreasessodiumcurrentsandneuronalexcitabilityinsmalldiametersensoryneurons